Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kim Orchard

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Bone Marrow Transplantation|March 4, 2026
Correction: Efficient bone marrow irradiation and low uptake by non-haematological organs with an yttrium-90-anti-CD66 antibody prior to haematopoietic stem cell transplantationKim Orchard, Jonathan Langford, Matthew Guy, et al.
Cancer Immunology, Immunotherapy : CII|April 27, 2011
Clinical evaluation of cellular immunotherapy in acute myeloid leukaemiaEvelien L J Smits, Cindy Lee, Nicola Hardwick, et al.
British Journal of Haematology|January 21, 2021
The NICE COVID-19 rapid guideline on haematopoietic stem cell transplantation: development, implementation and impactKim Orchard, Fiona L Dignan, Julia Lee, et al.
British Journal of Haematology|February 18, 2020
Serum profiling identifies ibrutinib as a treatment option for young adults with B-cell acute lymphoblastic leukaemiaStephanie Jordaens, Leah Cooksey, Stephanie Bonney, et al.
Oncotarget|February 10, 2018
Identification of survivin as a promising target for the immunotherapy of adult B-cell acute lymphoblastic leukemiaLaurie Freire Boullosa, Payalben Savaliya, Stephanie Bonney, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 20, 2010
Outcome following Reduced-Intensity Allogeneic Stem Cell Transplantation (RIC AlloSCT) for relapsed and refractory mantle cell lymphoma (MCL): a study of the British Society for Blood and Marrow TransplantationGordon Cook, Graeme M Smith, Keiren Kirkland, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 13, 2006
Long-term outcomes of myeloablation and autologous transplantation of relapsed acute myeloid leukemia in second remission: a British Society of Blood and Marrow Transplantation registry studyAndrew D Chantry, John A Snowden, Charles Craddock, et al.
The Lancet. Haematology|December 5, 2024
The impact of patient ethnicity on haematopoietic cell transplantation outcome: a retrospective cohort study on the UK experienceNeema P Mayor, Richard M Szydlo, Yasmin Sheikh, et al.
Journal for Immunotherapy of Cancer|July 20, 2024
Proteomic and phenotypic characteristics of memory-like natural killer cells for cancer immunotherapyHelena Arellano-Ballestero, Agnieszka Zubiak, Chris Dally, et al.
Haematologica|May 19, 2022
Impact of positron emission tomography - computed tomography status on progression-free survival for relapsed follicular lymphoma patients undergoing autologous stem cell transplantationToby A Eyre, Sally F Barrington, Jessica Okosun, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Bone Marrow Transplantation|March 4, 2026
Correction: Efficient bone marrow irradiation and low uptake by non-haematological organs with an yttrium-90-anti-CD66 antibody prior to haematopoietic stem cell transplantationKim Orchard, Jonathan Langford, Matthew Guy, et al.
Cancer Immunology, Immunotherapy : CII|April 27, 2011
Clinical evaluation of cellular immunotherapy in acute myeloid leukaemiaEvelien L J Smits, Cindy Lee, Nicola Hardwick, et al.
British Journal of Haematology|January 21, 2021
The NICE COVID-19 rapid guideline on haematopoietic stem cell transplantation: development, implementation and impactKim Orchard, Fiona L Dignan, Julia Lee, et al.
British Journal of Haematology|February 18, 2020
Serum profiling identifies ibrutinib as a treatment option for young adults with B-cell acute lymphoblastic leukaemiaStephanie Jordaens, Leah Cooksey, Stephanie Bonney, et al.
Oncotarget|February 10, 2018
Identification of survivin as a promising target for the immunotherapy of adult B-cell acute lymphoblastic leukemiaLaurie Freire Boullosa, Payalben Savaliya, Stephanie Bonney, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 20, 2010
Outcome following Reduced-Intensity Allogeneic Stem Cell Transplantation (RIC AlloSCT) for relapsed and refractory mantle cell lymphoma (MCL): a study of the British Society for Blood and Marrow TransplantationGordon Cook, Graeme M Smith, Keiren Kirkland, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 13, 2006
Long-term outcomes of myeloablation and autologous transplantation of relapsed acute myeloid leukemia in second remission: a British Society of Blood and Marrow Transplantation registry studyAndrew D Chantry, John A Snowden, Charles Craddock, et al.
The Lancet. Haematology|December 5, 2024
The impact of patient ethnicity on haematopoietic cell transplantation outcome: a retrospective cohort study on the UK experienceNeema P Mayor, Richard M Szydlo, Yasmin Sheikh, et al.
Journal for Immunotherapy of Cancer|July 20, 2024
Proteomic and phenotypic characteristics of memory-like natural killer cells for cancer immunotherapyHelena Arellano-Ballestero, Agnieszka Zubiak, Chris Dally, et al.
Haematologica|May 19, 2022
Impact of positron emission tomography - computed tomography status on progression-free survival for relapsed follicular lymphoma patients undergoing autologous stem cell transplantationToby A Eyre, Sally F Barrington, Jessica Okosun, et al.
Pageof 5